These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 21888082

  • 1. [Feasibility of alpha-blockers in chronic category III prostatitis].
    Altarac S, Cindro V, Radović N, Rajković Z, Belina S.
    Lijec Vjesn; 2011; 133(5-6):177-80. PubMed ID: 21888082
    [Abstract] [Full Text] [Related]

  • 2. Identification, pharmacologic considerations, and management of prostatitis.
    Schiller DS, Parikh A.
    Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307
    [Abstract] [Full Text] [Related]

  • 3. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
    Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN.
    J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
    [Abstract] [Full Text] [Related]

  • 4. [Alpha-blockers and bioflavonoids in men with chronic nonbacterial prostatitis (NIH-IIIa): a prospective, placebo-controlled trial].
    Lü M, Zhao ST, Wang SM, Shi BK, Fan YD, Wang JZ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):169-72. PubMed ID: 15132876
    [Abstract] [Full Text] [Related]

  • 5. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A, Alas P, Nickel JC, Sarpola A, Helström PJ.
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [Abstract] [Full Text] [Related]

  • 6. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS).
    Tuğcu V, Taşçi AI, Fazlioğlu A, Gürbüz G, Ozbek E, Sahin S, Kurtuluş F, Cek M.
    Eur Urol; 2007 Apr; 51(4):1113-7; discussion 1118. PubMed ID: 17084960
    [Abstract] [Full Text] [Related]

  • 7. Role of alpha1-blockers in chronic prostatitis syndromes.
    Nickel JC.
    BJU Int; 2008 Mar; 101 Suppl 3():11-6. PubMed ID: 18307680
    [Abstract] [Full Text] [Related]

  • 8. The effect of alpha-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials.
    Yang G, Wei Q, Li H, Yang Y, Zhang S, Dong Q.
    J Androl; 2006 Mar; 27(6):847-52. PubMed ID: 16870951
    [Abstract] [Full Text] [Related]

  • 9. Combination regimen in the treatment of chronic prostatitis.
    Chen WM, Yang CR, Ou YC, Ho HC, Su CK, Chiu KY, Cheng CL.
    Arch Androl; 2006 Mar; 52(2):117-21. PubMed ID: 16443588
    [Abstract] [Full Text] [Related]

  • 10. Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.
    Jeong CW, Lim DJ, Son H, Lee SE, Jeong H.
    Urol Int; 2008 Mar; 80(2):157-61. PubMed ID: 18362485
    [Abstract] [Full Text] [Related]

  • 11. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
    Nickel JC, Narayan P, McKay J, Doyle C.
    J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
    [Abstract] [Full Text] [Related]

  • 12. Comparison of results after fluoroquinolones and combination therapies in type IIIA chronic prostatitis.
    Altintas R, Oguz F, Beytur A, Ediz C, Gunes A, Ozer A.
    Actas Urol Esp; 2013 Apr; 37(10):619-24. PubMed ID: 23768504
    [Abstract] [Full Text] [Related]

  • 13. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.
    Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN.
    Urology; 2004 Nov; 64(5):881-6. PubMed ID: 15533470
    [Abstract] [Full Text] [Related]

  • 14. [Medication combined with local hyperthermia: a desirable therapy for chronic prostatitis pain symptoms].
    Zhang Y, Sun FL, Zang T.
    Zhonghua Nan Ke Xue; 2008 May; 14(5):451-3. PubMed ID: 18572868
    [Abstract] [Full Text] [Related]

  • 15. More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study.
    Paick JS, Lee SC, Ku JH.
    Prostate Cancer Prostatic Dis; 2006 May; 9(3):261-5. PubMed ID: 16683008
    [Abstract] [Full Text] [Related]

  • 16. Men suffering from category III chronic prostatitis may benefit from N-acetylcysteine as an adjunct to alpha-blockers.
    Yaryari AM, Mousavibahar SH, Amirhassani S, Bagheri M, Mohammadi Y, Mehrpooya M.
    Low Urin Tract Symptoms; 2022 May; 14(3):199-207. PubMed ID: 35068061
    [Abstract] [Full Text] [Related]

  • 17. [Results of monotherapy with terazosin (kornam) in chronic infectious prostatitis patients].
    Lopatkin NA, Apolikhin OI, Sivkov AV, Oshchepkov VN, Egorov AA.
    Urologiia; 2002 May; (5 Suppl):37-52. PubMed ID: 12518671
    [Abstract] [Full Text] [Related]

  • 18. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome.
    Nickel JC, Krieger JN, McNaughton-Collins M, Anderson RU, Pontari M, Shoskes DA, Litwin MS, Alexander RB, White PC, Berger R, Nadler R, O'Leary M, Liong ML, Zeitlin S, Chuai S, Landis JR, Kusek JW, Nyberg LM, Schaeffer AJ, Chronic Prostatitis Collaborative Research Network.
    N Engl J Med; 2008 Dec 18; 359(25):2663-73. PubMed ID: 19092152
    [Abstract] [Full Text] [Related]

  • 19. [Clinical application of alpha1 adrenoceptor antagonist Naftopidil to the treatment of chronic non-bacterial prostatitis].
    Li X, Li NC, Ding Q, Cai SL, Huo HX, Chen SY, Gu XJ, Chen SP, Na YQ.
    Zhonghua Nan Ke Xue; 2006 Mar 18; 12(3):234-6, 239. PubMed ID: 16597040
    [Abstract] [Full Text] [Related]

  • 20. Chronic prostatitis/chronic pelvic pain syndrome: role of alpha blocker therapy.
    Lee SW, Liong ML, Yuen KH, Liong YV, Krieger JN.
    Urol Int; 2007 Mar 18; 78(2):97-105. PubMed ID: 17293646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.